[go: up one dir, main page]

Jump to content

Sotalol

From Simple English Wikipedia, the free encyclopedia
Sotalol
Clinical data
Trade namesBetapace, Sorine, Sotylize, others[1]
AHFS/Drugs.comMonograph
MedlinePlusa693010
License data
Pregnancy
category
  • AU: C
Routes of
administration
By mouth
Drug classBeta blocker
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability90–100%[2]
MetabolismNot metabolized[2]
Elimination half-life12 hours[2]
ExcretionKidney
Mammary gland (In lactating individuals)[2]
Identifiers
  • (RS)-N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC12H20N2O3S
Molar mass272.36 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=S(=O)(Nc1ccc(cc1)C(O)CNC(C)C)C
  • InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3 checkY
  • Key:ZBMZVLHSJCTVON-UHFFFAOYSA-N checkY
  (verify)

Sotalol (brand names Betapace, Betapace AF, Sorine, and Sotylize) belongs to a group of medicines called beta blockers. It is used to treat atrial fibrillation and other conditions that cause an irregular heartbeat (arrhythmia).[3] It starts to work after about 4 hours, but it can take 2 to 3 days to fully take effect.[3]

[change | change source]

References

[change | change source]
  1. "Sotalol Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 18 March 2019.
  2. 2.0 2.1 2.2 2.3 U.S. Food and Drug Administration (July 2009). "Sotalol: Full Prescribing Information" (PDF). Retrieved 23 April 2015.
  3. 3.0 3.1 "Sotalol: medicine to treat an irregular heartbeat". nhs.uk. 2018-08-29. Retrieved 2024-06-05.